Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)最新文献_第9页

[Síndrome de fiebre periódica, adenitis, faringitis y aftosis en un preescolar con síndrome de Asperger: reporte de caso]. [阿斯伯格综合症学龄前儿童的周期性发烧、腺炎、咽炎和口蹄疫综合征：病例报告]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1260

Raúl Alberto Montero-Vázquez

{"title":"[Síndrome de fiebre periódica, adenitis, faringitis y aftosis en un preescolar con síndrome de Asperger: reporte de caso].","authors":"Raúl Alberto Montero-Vázquez","doi":"10.29262/ram.v70i3.1260","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1260","url":null,"abstract":"Background: Autoinflammatory diseases are a heterogeneous group of pathologies whose prevalence is undefined to date. Within these, the Periodic Fever Syndrome, Adenitis, Pharyngitis and Aphthosis (PFAPA) is determined as the most common and the most studied. Neurodevelopmental and behavioral disor- ders, including those of the Autism Spectrum, are especially prevalent in patients with allergic and autoimmune diseases, however, there is little documented regarding their relationship with autoinflammation.Case report: The case of a patient with Asperger Syndrome with subsequent onset of this autoinflammatory disease is shown. Two weekly blood counts and complete serum immunoglobulins are obtained, which do not show a decrease in neutrophil counts or sublevels or supralevels in immunoglobulins.Conclusion: When he returned to his follow-up appointment, he reported a feverish peak 2 days before, which ceased with the administration of the steroid, and if there was presence of oral ulcers on this occasion, fulfilling the modified Marshall criteria. Likewise, a great change is noted in their development and cooper- ation in exploration. The duality of this autoinflammatory syndrome in a patient with Asperger Syndrome is determined.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"200"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Anafilaxia perioperatoria a sevoflurano, un caso muy raro]. [七氟醚围手术期过敏，非常罕见的病例]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1271

Andrea Guadalupe González-Vallejo, E Hernandez-López

{"title":"[Anafilaxia perioperatoria a sevoflurano, un caso muy raro].","authors":"Andrea Guadalupe González-Vallejo, E Hernandez-López","doi":"10.29262/ram.v70i3.1271","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1271","url":null,"abstract":"Background: Perioperative anaphylaxis can be life-threatening. The global incidence is estimated to be 1 in 10,000-20,000 procedures. The most common agents are neuromuscular blockers, latex, and antibiotics. There are very few reports of allergies to inhaled anesthetics such as sevoflurane, which is considered relatively safe in patients with drug allergies.Case report: 12-year-old patient, admitted to oncology, diagnosed with acute lymphoblastic leukemia. History of two perioperative hypersensitivity reactions. In the first event, lidocaine and rupivacaine were administered, he presented urticaria, managed with an antihistamine. On the second occasion, he received only sevoflurane and presented anaphylaxis, treated with intramuscular adrenaline. Later during intrathecal therapy, he received sevoflurane, he presented rash and arterial hypotension, managed again with adrenaline, with total remission of symptoms. Retrospectively Brighton criteria level I of certainty, classified as serious by Brown. Hypersensitivity to sevoflurane was suspected, ruling out other anesthetics such as lidocaine and rupivacaine with negative intradermal skin tests. Molecular components for latex were requested with negative results for Hev b 1, Hev b 3, Hev b 6. Due to the above and associated with the characteristics of the drug, a basophil activation test for sevoflurane was performed with an activation percentage of 50% (positive). Perioperative anaphylaxis due to sevoflurane is confirmed.Conclusion: All drugs involved in perioperative hypersensitivity reactions should be considered to establish adequate and safe treatment alternatives for this small group of patients.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"195"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Desensibilización a Rituximab en paciente con proteinuria persistente secundaria a LES]. [SLE继发持续性蛋白尿患者对利妥昔单抗的脱敏]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1288

Nayeli Servín-Suárez, Alicia Méndez-Gómez, Karla Korkowski-Uviña, Héctor Carrillo-Murillo, Eduardo Torres-Rojo, Margarita Ortega-Cisneros, Itzel Vianey Ochoa-García

{"title":"[Desensibilización a Rituximab en paciente con proteinuria persistente secundaria a LES].","authors":"Nayeli Servín-Suárez, Alicia Méndez-Gómez, Karla Korkowski-Uviña, Héctor Carrillo-Murillo, Eduardo Torres-Rojo, Margarita Ortega-Cisneros, Itzel Vianey Ochoa-García","doi":"10.29262/ram.v70i3.1288","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1288","url":null,"abstract":"Introduction: Rituximab is an Anti-CD20 chimeric monoclonal antibody, being the treatment of lymphoproliferative diseases and rheumatological disorders; hypersensitivity reactions (HRS) are associated with infusion, cytokine release, type I (IgE/non-IgE), mixed, type III and IV. Desensitization seeks to induce tem- porary tolerance, decreasing the probability of clinical manifestations through gradual administration of the total dose of the drug, being target cells of the procedure, basophils, and mast cells, preventing their activation.Case report: The objective is to present a personalized desensitization protocol in a 36-year-old female patient with systemic lupus erythematosus (SLE) pre- viously treated with rituximab in 2019, 4 doses, presenting during the fourth administration, after 10 minutes, dyspnea, feeling foreign body in the pharynx, chest pain, angioedema, and neurological alteration. Requiring new administration of rituximab due to persistent proteinuria secondary to SLE. After performing skin tests (negative), a 13-step desensitization scheme was performed with 3 concentrations (solution: A [1:100], B [1:10] and C [1:1]). Since only 52% of RHS to rituximab are positive in skin tests and given the degree of reaction (serious), desensitization is decided, based on reactions presented by patient and clinical context. Achieving a cumulative dose of 897.87 mg in a period of 5 hours, without reactions during or after the procedure, concluding successfully.Conclusion: By carrying out desensitization protocols, the administration of a drug is allowed, offering a safe therapeutic option, when this is the treatment of choice in previously sensitized patients, offering an alternative when the benefits outweigh the risks of its administration.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Eccema herpético en una paciente con dermatitis atópica]. [特应性皮炎患者的疱疹性湿疹]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1212

Mario René Pavía Espinosa, Cristian Jesús Huchim Peña, Erick André Escalante Buendía, Emiliano Catana Gallegos, Paulina Pacheco Pino

引用次数: 0

[Síndrome hemofagocítico linfohistiocitario secundario a Dengue en una paciente de 6 años: reporte de caso]. [一名6岁患者继发于登革热的淋巴细胞吞噬综合征：病例报告]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1253

Raúl Alberto Montero-Vázquez, Andrea Valdes-Mosso, Claudia Marcela Mendez-Contreras

{"title":"[Síndrome hemofagocítico linfohistiocitario secundario a Dengue en una paciente de 6 años: reporte de caso].","authors":"Raúl Alberto Montero-Vázquez, Andrea Valdes-Mosso, Claudia Marcela Mendez-Contreras","doi":"10.29262/ram.v70i3.1253","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1253","url":null,"abstract":"Background: Dengue fever is a mosquito-borne infectious disease endemic in over 100 countries around the world. Among the complications that dengue can cause the Hemophagocytic Lymphohistiocytosis is one of great concern for its severity and complex diagnosis.Case report: Hereby we document a case of this disease expressed on a previously healthy 6-year-old female patient whose dengue infection was so severe that needed intensive care management with vasoactive drugs and diuretics. After a short period of wellness began newly with fever, pancytopenia, hepatitis, and inflammatory response symptoms.Conclusions: A Dengue associated Hemophagocytic Lymphohistiocytosis syndrome was suspected and treated with intravenous corticosteroids on a 3-day scheme at no signs of malignancy with excellent response. The health care professionals must know about this not novel entity in order to reach an efficient diagnosis and treatment mostly, but not only, those in tropical and sub-tropical regions of the word were dengue virus is endemic.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"204"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hereditary angioedema: Patient journey approach in Mexico. 遗传性血管性水肿：墨西哥的患者旅程方法。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1250

María Eugenia Vargas Camaño, Yareli Odemaris Buendía López, Homero Garcés Flores, Silvia Guzmán Vázquez

{"title":"Hereditary angioedema: Patient journey approach in Mexico.","authors":"María Eugenia Vargas Camaño, Yareli Odemaris Buendía López, Homero Garcés Flores, Silvia Guzmán Vázquez","doi":"10.29262/ram.v70i3.1250","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1250","url":null,"abstract":"Objective: To understand the patient's journey with HAE from symptom initiation to diagnosis, treatment allocation, follow-up, and the impact of the disease on their quality of life in Mexico.Methods: A survey was administered to the patients with HAE. Participants completed a questionnaire covering five domains: patient journey; effects on productivity, school performance and daily activities; quality of life; anxiety and depression. Responses were analyzed using descriptive statistics.Results: A total of 17 surveys were analyzed (15 women and 2 men, age range: 23-67 years). Type I HAE was most common (71%), normal C1 inhibitor HAE was 12% and 18% did not know their HAE type. The average disease evolution was 13.7 years and the time from symptom initiation to diagnosis was 20 years. 59% of patients knew of one or two treatments available, 12% knew 3 treatments and 18% were aware of 4 or more, 12% were not aware of any treatments. 53% had a job, 18% referred a severely anxious state, 41% were depressed and all patients referred some social impact due to HAE.Conclusions: There is a need to reinforce the knowledge of general practitioners on HAE to promote an earlier diagnosis and awareness of rare diseases and their impact on quality of life among the general population and promote the removal of barriers to treatment.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"121-128"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Diagnóstico de alergia inmediata para penicilina: estudio piloto]. [青霉素立即过敏诊断：初步研究]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1261

Julinela Armenta-Morales, Dulce Mariel Ruiz-Sánchez, Daniela Rivero-Yeverino, José Sergio Papaqui-Tapia, Juan Jesús Rios-López, Aida Inés Lopez-Garcia, Chrystopherson Caballero-López, Yosahandi Pacheco-Jiménez

{"title":"[Diagnóstico de alergia inmediata para penicilina: estudio piloto].","authors":"Julinela Armenta-Morales, Dulce Mariel Ruiz-Sánchez, Daniela Rivero-Yeverino, José Sergio Papaqui-Tapia, Juan Jesús Rios-López, Aida Inés Lopez-Garcia, Chrystopherson Caballero-López, Yosahandi Pacheco-Jiménez","doi":"10.29262/ram.v70i3.1261","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1261","url":null,"abstract":"Objectives: To confirm the presence of allergy to penicillin and amoxicillin by in vivo exposure tests in patients with a history of immediate reaction to these drugs. Methods: Observational, cross-sectional, descriptive and prolective study. Patients between 12 and 60 years old with a history of immediate reaction after administration of penicillin and/or amoxicillin were included. Skin prick and intradermal tests were performed with benzylpenicilloyl polylysine and penicillin G, as well as oral challenge with amoxicillin.Results: Ten female and 3 male patients were included. The mean age was 39 years. In 84.6% of the cases the last adverse drug reaction occurred 10 years ago and in all cases it manifested with urticaria. Allergy to penicillin was corroborated in only 38.4% of cases. The most frequent adverse reaction after in vivo exposure tests was pruritus in 23%.Conclusions: Patients with suspected penicillin allergy should be evaluated by in vivo exposure testing with major and minor determinants to corroborate or rule out allergic reactions and improve treatment conditions.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"191"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Control de asma grave predominantemente eosinofílica con el uso de anti IL-5]. [使用抗IL-5控制以嗜酸性粒细胞为主的严重哮喘]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1269

Martha Alicia Ruiz-Peñaloza, José Jesús López-Tiro, Zayra Estefania Ortíz-Monteón, Carolina García-Rosas

{"title":"[Control de asma grave predominantemente eosinofílica con el uso de anti IL-5].","authors":"Martha Alicia Ruiz-Peñaloza, José Jesús López-Tiro, Zayra Estefania Ortíz-Monteón, Carolina García-Rosas","doi":"10.29262/ram.v70i3.1269","DOIUrl":"10.29262/ram.v70i3.1269","url":null,"abstract":"Background: Asthma is a chronic inflammatory disease of the airways, caused by inflammatory cells and mediators, associated with smooth muscle dysfunction, causing variable airflow obstruction. With high, low and mixed type 2 immunoinflammatory mechanisms (endotypes). Severe asthma is that which requires step 4 or 5 of treatment (GINA 2023). The TH2 High phenotype, non-allergic with eosinophilia and FENO, is the second most common. It affects 300 million people around the world.Objetive: Describe asthma biomarkers after the use of antiinterleukin 5, Benralizumab, in adults with severe asthma.Methods: Case report, descriptive study. Patients with severe eosinophilic asthma and chronic polyposis rhinosinusitis under treatment with anti-IL5 were included, evaluating inflammatory biomarkers.Results: Serum eosinophils, FENO, ACT, spirometry, and exacerbations were measured in 8 patients at baseline and 6 months after treatment. The FEV1-FVC was 51% with improvement up to 95% later. 5 patients had FENO > 45 ppm subsequently only 3 continued to be inflamed. Eosinophilia 150 cells and subsequently only 1 patient persisted with eosinophilia 200 cells. Initial ACT < 19 in 7 patients Final ACT >19 in 7 patients. Exacerbations 8 patients with 2 or more exacerba- tions subsequently only 1 patient presented exacerbation.Conclusion: The use of anti-interleukin 5 (benralizumab) does reduce inflammatory markers, improves control and number of exacerbations in the short term. Monoclonal antibodies (Anti IL-5), if they improve inflammatory biomarkers, if clinical characteristics and inflammatory biomarkers are taken into account, it favors adequate asthma control.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"199"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Pruebas diagnósticas in vivo en alergia inmediata a penicilina: estudio piloto]. [立即对青霉素过敏的体内诊断测试：初步研究]。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1254

Dulce Mariel Ruiz-Sánchez, Daniela Rivero-Yeverino, José Sergio Papaqui-Tapia, Chrystopherson Gengyny Caballero-López, Aida Inés López-García, Juan Jesús Rios-López, Edgar Flores-Gonzaga, Erika Villada-Villada

{"title":"[Pruebas diagnósticas in vivo en alergia inmediata a penicilina: estudio piloto].","authors":"Dulce Mariel Ruiz-Sánchez, Daniela Rivero-Yeverino, José Sergio Papaqui-Tapia, Chrystopherson Gengyny Caballero-López, Aida Inés López-García, Juan Jesús Rios-López, Edgar Flores-Gonzaga, Erika Villada-Villada","doi":"10.29262/ram.v70i3.1254","DOIUrl":"10.29262/ram.v70i3.1254","url":null,"abstract":"Background: The most commonly reported antibiotic allergy is penicillin. The false label of \"allergy\" to penicillin negatively affects the patient's quality of life and medical care.Objective: To determine the frequency of allergy to penicillin and amoxicillin by in vivo exposure tests in patients with a history of immediate reaction to this class of medicinal products.Methods: Observational, cross-sectional, descriptive and prolective study in patients between 12 and 60 years of age with a history of immediate reaction to penicillin and/or amoxicillin. Prick and intradermal skin tests were performed with benzylpenicilloyl polylysine (Pre-Pen), penicillin G and oral challenge test with amoxicillin. The frequency of positivity and negativity in these tests was calculated with a 95% CI. Results were analyzed in Epi info 7.2.5.0.Results: In total 13 patients (10 women) were included, with a mean age of 39 years (SD 12.14). In 84.6% the last adverse drug reaction occurred 10 years ago and in all manifested with urticaria. The 38.4% confirmed penicillin allergy and the most frequent adverse reaction after in vivo tests was pruritus.Conclusions: The clinical history alone is not sufficient, all patients with suspected penicillin allergy should be evaluated by in vivo exposure tests with major and minor determinants to corroborate or rule out allergy to this pharmacological class.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"205"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71491024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[¿Anafilaxia perioperatoria? Serie de casos]. [¿Anafilaxia perioperatoria ?casos系列)。

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) Pub Date : 2023-09-01 DOI: 10.29262/ram.v70i3.1273

Alicia Méndez-Gómez, Nayeli Servín-Suárez, Héctor Carrillo-Murillo, Eduardo Torres-Rojo, Karla Korkowski-Uviña, Itzel Vianney Ochoa-García

{"title":"[¿Anafilaxia perioperatoria? Serie de casos].","authors":"Alicia Méndez-Gómez, Nayeli Servín-Suárez, Héctor Carrillo-Murillo, Eduardo Torres-Rojo, Karla Korkowski-Uviña, Itzel Vianney Ochoa-García","doi":"10.29262/ram.v70i3.1273","DOIUrl":"https://doi.org/10.29262/ram.v70i3.1273","url":null,"abstract":"Objective: Identify the causative agent of POH, to avoid re-exposure and assess the use of alternative treatment.Methods: 10 cases of immediate POH are described, in all of them a history of previous surgical procedures, carrying out a 3-step protocol: 1st documenting the surgical record to identify exposures, 2nd performing skin and/or epicutaneous tests and 3rd searching for an alternative treatment. treatment if a new surgical procedure is required and in selected cases challenge tests.Results: Of a total of 10 patients with immediate POH, tests were performed according to the case: neuromuscular blockers, anesthetics, opioids, NSAIDs, anti- biotics, diuretics, latex, isodine, and chlorhexidine; finding positive tests in 7 (70%) patients: in 4 (40%) neuromuscular blockers, one of them also positive for latex, in 2 (20%) anesthetics and finally finding a pharmacological alternative in 2 (2%) and recommending free operating room latex in 2 cases (20%), the rest (30%) were classified as related to the surgical procedure and medication management.Conclusions: The study of POH is focused on ensuring safety in subsequent exposures, so in addition to identifying the causative agent, the role of the allergist also leads to a search for a safe alternative in patient management.","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"70 4","pages":"187"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107593197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0